In our study, methylation of the FMOD gene body in PAAD was associated with response to the Hsp90 inhibitor 17-AAG (17-allylamino-17-demethoxygeldanamycin; Additional file 15: Table S15). The gene discussed is FMOD; the disease is pancreatic adenocarcinoma.